<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02971267</url>
  </required_header>
  <id_info>
    <org_study_id>SFB/TR19plus-001</org_study_id>
    <nct_id>NCT02971267</nct_id>
  </id_info>
  <brief_title>Follow-up of the Cardiomyopathy Cohort SFB/TR19</brief_title>
  <acronym>SFB/TR19plus</acronym>
  <official_title>Follow-up of the Inflammatory Cardiomyopathy Cohort of SFB/TR19</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medicine Greifswald</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medicine Greifswald</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Follow-up of a cohort of inflammatory cardiomyopathy patients (suspected or validated
      inflammatory cardiomyopathy) recruited at baseline by the SFB-TR19 project. Standardized
      protocols will be used for the assessment of medical history and examinations, laboratory
      biomarkers, and the collection of various biomaterials for biobanking purposes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Periodical follow-up of a cohort of inflammatory cardiomyopathy patients (suspected or
      validated inflammatory cardiomyopathy) recruited at baseline by the SFB/TR19 project.
      Participants will be followed up at least every year - or more frequently based on clinical
      need. Standardized protocols will be used for the assessment of medical history and
      examinations, laboratory biomarkers, and the collection of various biomaterials for
      biobanking purposes.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of cardiovascular events</measure>
    <time_frame>1-year follow-ups up to 10 years</time_frame>
    <description>Number of hospitalization (HF based. all-cause), interventions (ICD, pacemaker), myocardial infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>LVEF (left ventricular ejection fraction)</measure>
    <time_frame>1-year follow-ups up to 10 years</time_frame>
    <description>Left ventricular ejection fraction at time of follow-ups (through study completion, every year)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VO2peak</measure>
    <time_frame>1-year follow-ups up to 10 years</time_frame>
    <description>Exercise capacity by CPET (cardiopulmonary exercise testing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>QOL</measure>
    <time_frame>1-year follow-ups up to 10 years</time_frame>
    <description>Quality of life by MLHF questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>1-year follow-ups up to 10 years</time_frame>
    <description>Mortality (HF-related, cardiovascular disease, all-cause mortality)</description>
  </secondary_outcome>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiomyopathies</condition>
  <condition>Heart Failure</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>None, observational only</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with suspected or validated inflammatory cardiomyopathy at baseline
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Participation in baseline examination of SFB/TR19

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Marcus Dörr, MD</last_name>
    <phone>+49383486</phone>
    <phone_ext>80500</phone_ext>
    <email>mdoerr@uni-greifswald.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stephan B Felix, MD</last_name>
    <phone>+49383486</phone>
    <phone_ext>80500</phone_ext>
    <email>felix@uni-greifswald.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Internal Medicine B, University Medicine Greifswald</name>
      <address>
        <city>Greifswald</city>
        <state>MV</state>
        <zip>17475</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Dörr, MD</last_name>
      <phone>+49383486</phone>
      <phone_ext>80500</phone_ext>
      <email>mdoerr@uni-greifswald.de</email>
    </contact>
    <contact_backup>
      <last_name>Stephan B Felix, MD</last_name>
      <phone>+49383486</phone>
      <phone_ext>80500</phone_ext>
      <email>felix@uni-greifswald.de</email>
    </contact_backup>
    <investigator>
      <last_name>Kristin Lehnert, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sabine Kaczmarek, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ann Louise Pedersen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 9, 2016</study_first_submitted>
  <study_first_submitted_qc>November 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2016</study_first_posted>
  <last_update_submitted>November 19, 2016</last_update_submitted>
  <last_update_submitted_qc>November 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>heart failure</keyword>
  <keyword>cardiomyopathy</keyword>
  <keyword>myocarditis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

